Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 368

1.

Advances in the treatment of Crohn's disease.

Egan LJ, Sandborn WJ.

Gastroenterology. 2004 May;126(6):1574-81. Review.

PMID:
15168368
2.

Local injection of Infliximab for the treatment of perianal Crohn's disease.

Poggioli G, Laureti S, Pierangeli F, Rizzello F, Ugolini F, Gionchetti P, Campieri M.

Dis Colon Rectum. 2005 Apr;48(4):768-74.

PMID:
15768185
3.

Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.

Sandborn WJ, Feagan BG, Lichtenstein GR.

Aliment Pharmacol Ther. 2007 Oct 1;26(7):987-1003. Review.

4.

Review article: The medical treatment of Crohn's perianal fistulas.

Schwartz DA, Herdman CR.

Aliment Pharmacol Ther. 2004 May 1;19(9):953-67. Review.

5.

Review article: treatment of perianal fistulizing Crohn's disease.

Rutgeerts P.

Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:106-10. Review.

6.

Review article: medical treatment of mild to moderately active Crohn's disease.

Löfberg R.

Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:18-22. Review.

7.

[What can be expected from biological therapies for Crohn's disease?].

Lemann M.

Gastroenterol Clin Biol. 2001 Nov;25(11):945-7. Review. French. No abstract available.

8.

What is the optimal maintenance treatment for perianal Crohn's disease?

Schwartz DA.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S269-70. doi: 10.1002/ibd.20673. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816761
9.

Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.

Sandborn WJ, Feagan BG.

Aliment Pharmacol Ther. 2003 Aug 1;18(3):263-77. Review.

10.

Faecal diversion in the management of perianal Crohn's disease.

Hong MK, Craig Lynch A, Bell S, Woods RJ, Keck JO, Johnston MJ, Heriot AG.

Colorectal Dis. 2011 Feb;13(2):171-6. doi: 10.1111/j.1463-1318.2009.02092.x.

PMID:
19863597
11.

[Indications and results of infliximab in Crohn's disease].

Karoui S, Boubaker J, Filali A.

Tunis Med. 2004 Dec;82(12):1057-63. Review. French.

PMID:
15822505
12.
13.

Perianal Crohn's disease (Br J Surg 2004; 91: 801-814).

Olaison G, Almer S, Anderson P.

Br J Surg. 2004 Oct;91(10):1381. No abstract available.

PMID:
15382098
14.

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.

Dig Liver Dis. 2004 May;36(5):342-7.

PMID:
15191204
15.

Metastatic Crohn's disease responding to metronidazole.

Duhra P, Paul CJ.

Br J Dermatol. 1988 Jul;119(1):87-91.

PMID:
3408668
16.

Mild to moderate Crohn's disease: still room for step-up therapies?

Bar-Meir S.

Dig Dis. 2009;27(3):347-50. doi: 10.1159/000228572. Epub 2009 Sep 24. Review.

PMID:
19786763
17.

Current treatment modalities in active Crohn's disease.

Biancone L, Pallone F.

Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):508-14. Review.

PMID:
10575571
18.
19.
20.

Successful use of infliximab for perianal Crohn's disease in pregnancy.

Chaparro M, Gisbert JP.

Inflamm Bowel Dis. 2011 Mar;17(3):868-9. doi: 10.1002/ibd.21368. No abstract available.

PMID:
20564533

Supplemental Content

Support Center